Cargando…

Distinct immune response to CoronaVac in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic disease

Detalles Bibliográficos
Autores principales: Gao, Xing-Su, Zhu, Feng-Cai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641957/
https://www.ncbi.nlm.nih.gov/pubmed/34901883
http://dx.doi.org/10.1016/S2665-9913(21)00392-1
_version_ 1784609590400253952
author Gao, Xing-Su
Zhu, Feng-Cai
author_facet Gao, Xing-Su
Zhu, Feng-Cai
author_sort Gao, Xing-Su
collection PubMed
description
format Online
Article
Text
id pubmed-8641957
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-86419572021-12-06 Distinct immune response to CoronaVac in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic disease Gao, Xing-Su Zhu, Feng-Cai Lancet Rheumatol Comment Elsevier Ltd. 2022-02 2021-12-03 /pmc/articles/PMC8641957/ /pubmed/34901883 http://dx.doi.org/10.1016/S2665-9913(21)00392-1 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Comment
Gao, Xing-Su
Zhu, Feng-Cai
Distinct immune response to CoronaVac in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic disease
title Distinct immune response to CoronaVac in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic disease
title_full Distinct immune response to CoronaVac in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic disease
title_fullStr Distinct immune response to CoronaVac in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic disease
title_full_unstemmed Distinct immune response to CoronaVac in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic disease
title_short Distinct immune response to CoronaVac in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic disease
title_sort distinct immune response to coronavac in sars-cov-2 seropositive and seronegative patients with autoimmune rheumatic disease
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641957/
https://www.ncbi.nlm.nih.gov/pubmed/34901883
http://dx.doi.org/10.1016/S2665-9913(21)00392-1
work_keys_str_mv AT gaoxingsu distinctimmuneresponsetocoronavacinsarscov2seropositiveandseronegativepatientswithautoimmunerheumaticdisease
AT zhufengcai distinctimmuneresponsetocoronavacinsarscov2seropositiveandseronegativepatientswithautoimmunerheumaticdisease